大行评级｜摩根大通：辉瑞首季核心产品销售符合预期维持“中性”评级

格隆汇资讯05-02

摩根大通发表研报指，辉瑞首季核心产品Paxlovid销售表现符合预期，毛利率更超出预期达到近80%，对比该公司全年指引为约70%。虽然辉瑞管理层今次未有调整产品销售额及毛利率全年指引，但摩通相信投资者不会对辉瑞今年业绩表现持续增长或调整指引感到惊讶，将今明两年经调整每股盈利预测上调至2.45及2.57美元，对比今年度公司指引为介乎2.15至2.35美元。目前该行的2024年销售额预测为609亿美元...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2432909607?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-05-02 22:17","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2432909607","market":"us","top_or_hot":-1,"title":"大行评级｜摩根大通：辉瑞首季核心产品销售符合预期 维持“中性”评级","media":"格隆汇资讯","content":"<div>\n<p>摩根大通发表研报指，辉瑞首季核心产品Paxlovid销售表现符合预期，毛利率更超出预期达到近80%，对比该公司全年指引为约70%。虽然辉瑞管理层今次未有调整产品销售额及毛利率全年指引，但摩通相信投资者不会对辉瑞今年业绩表现持续增长或调整指引感到惊讶，将今明两年经调整每股盈利预测上调至2.45及2.57美元，对比今年度公司指引为介乎2.15至2.35美元。目前该行的2024年销售额预测为609亿美元...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022217448b6d4761&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>大行评级｜摩根大通：辉瑞首季核心产品销售符合预期 维持“中性”评级</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n大行评级｜摩根大通：辉瑞首季核心产品销售符合预期 维持“中性”评级\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-02 22:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022217448b6d4761&s=b><strong>格隆汇资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>摩根大通发表研报指，辉瑞首季核心产品Paxlovid销售表现符合预期，毛利率更超出预期达到近80%，对比该公司全年指引为约70%。虽然辉瑞管理层今次未有调整产品销售额及毛利率全年指引，但摩通相信投资者不会对辉瑞今年业绩表现持续增长或调整指引感到惊讶，将今明两年经调整每股盈利预测上调至2.45及2.57美元，对比今年度公司指引为介乎2.15至2.35美元。目前该行的2024年销售额预测为609亿美元...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022217448b6d4761&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022217448b6d4761&s=b","article_id":"2432909607","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022217448b6d4761&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2432909607","pubTimestamp":1714659460,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"摩根大通发表研报指，辉瑞首季核心产品Paxlovid销售表现符合预期，毛利率更超出预期达到近80%，对比该公司全年指引为约70%。考虑到辉瑞的股价在短期内或会波动，该行维持“中性”评级，认为要有更强劲的新药销售表现或管线的进一步进展，市场才会明显改变现有看法，目标价为30美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"PFE":"辉瑞"},"translate_title":"Major bank ratings | JPMorgan Chase: Pfizer's core product sales in the first quarter are in line with expectations and maintain a \"neutral\" rating","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":1},"content_text":"摩根大通发表研报指，辉瑞首季核心产品Paxlovid销售表现符合预期，毛利率更超出预期达到近80%，对比该公司全年指引为约70%。虽然辉瑞管理层今次未有调整产品销售额及毛利率全年指引，但摩通相信投资者不会对辉瑞今年业绩表现持续增长或调整指引感到惊讶，将今明两年经调整每股盈利预测上调至2.45及2.57美元，对比今年度公司指引为介乎2.15至2.35美元。目前该行的2024年销售额预测为609亿美元，处于公司业绩指引585亿至615亿美元的近上限区间，主要来自于核心产品Paxlovid销售增长及去年收购癌症药物生产商Seagen的贡献，全年毛利率亦提升至72.7%。考虑到辉瑞的股价在短期内或会波动，该行维持“中性”评级，认为要有更强劲的新药销售表现或管线的进一步进展，市场才会明显改变现有看法，目标价为30美元。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2432909607"}

大行评级｜摩根大通：辉瑞首季核心产品销售符合预期 维持“中性”评级

精彩评论

大行评级｜摩根大通：辉瑞首季核心产品销售符合预期维持“中性”评级